ANNDEXA Trademark

Trademark Overview

On Friday, July 24, 2015, a trademark application was filed for ANNDEXA with the United States Patent and Trademark Office. The USPTO has given the ANNDEXA trademark a serial number of 86704100. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 7, 2019. This trademark is owned by Portola Pharmaceuticals, Inc.. The ANNDEXA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in oncology and hematology; pharmaceutical preparations for the treatment of coagulation disorders, thrombosis, hematologic cancers, and inflammation
anndexa

General Information

Serial Number86704100
Word MarkANNDEXA
Filing DateFriday, July 24, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 7, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 6, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in oncology and hematology; pharmaceutical preparations for the treatment of coagulation disorders, thrombosis, hematologic cancers, and inflammation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 30, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePortola Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NamePortola Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Monday, January 7, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 7, 2019ABANDONMENT - NO USE STATEMENT FILED
Saturday, June 2, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 1, 2018EXTENSION 5 GRANTED
Wednesday, May 30, 2018EXTENSION 5 FILED
Wednesday, May 30, 2018TEAS EXTENSION RECEIVED
Wednesday, November 29, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 27, 2017EXTENSION 4 GRANTED
Monday, November 27, 2017EXTENSION 4 FILED
Monday, November 27, 2017TEAS EXTENSION RECEIVED
Wednesday, May 24, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 22, 2017EXTENSION 3 GRANTED
Monday, May 22, 2017EXTENSION 3 FILED
Monday, May 22, 2017TEAS EXTENSION RECEIVED
Wednesday, November 23, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 22, 2016EXTENSION 2 GRANTED
Wednesday, November 2, 2016EXTENSION 2 FILED
Thursday, November 17, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 2, 2016TEAS EXTENSION RECEIVED
Wednesday, May 18, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 16, 2016EXTENSION 1 GRANTED
Monday, May 16, 2016EXTENSION 1 FILED
Monday, May 16, 2016TEAS EXTENSION RECEIVED
Monday, May 2, 2016TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, December 1, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 6, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 6, 2015PUBLISHED FOR OPPOSITION
Wednesday, September 16, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 27, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 25, 2015ASSIGNED TO EXAMINER
Thursday, July 30, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, July 28, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

anndexa pharmaceutical preparations hematologic inflammation thrombosis cancers coagulation oncology hematology treatment